Optimising long-acting Testosterone Replacement Therapy: Delivering clinical value without compromise (Clinical lunch chat held on 1 September 2026)

This practical CME discussion explores how clinicians can optimise long-acting testosterone replacement therapy, from establishing a robust diagnosis and selecting the appropriate patient to understanding formulation differences, treatment expectations, monitoring and long-term safety.
Learning Outcomes
- Diagnose male hypogonadism appropriately, combining compatible symptoms with confirmed biochemical testosterone deficiency
- Select appropriate patients for TRT and recognise contraindications and situations requiring specialist assessment
- Differentiate between testosterone formulations, including the clinical implications of short- versus long-acting treatment
- Recognise and manage common treatment challenges, including erythrocytosis, inadequate response, fluctuating symptoms and fertility considerations.
- Individualise long-term TRT according to clinical response, safety, patient preference and treatment burden.
To access this module, please register or login:
